| Tag | Content |
|---|
EnhancerAtlas ID | HS076-28600 |
Organism | Homo sapiens |
Tissue/cell | H1 |
Coordinate | chr19:17371520-17372280 |
Target genes | | Number: 29 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr19:17371841-17371860 | CCGCCACCAGAGGGCGCCT | + | 7.05 | | IRF1 | MA0050.2 | chr19:17372114-17372135 | GTTTTCTTTCTTTTTCTTTCT | + | 6.21 | | IRF1 | MA0050.2 | chr19:17372136-17372157 | TCTTTCTTTCTTTTTTTTTTT | + | 6.25 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_47714 | chr19:17371376-17371785 | Pancreas | | SE_47714 | chr19:17371795-17372144 | Pancreas | | SE_57118 | chr19:17371817-17372146 | VACO_400 | | SE_68828 | chr19:17371559-17372228 | H9 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr19 | 17371801 | 17372164 | | chr19 | 17371829 | 17372200 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I017261 | chr19 | 17371281 | 17372175 |
|
Enhancer Sequence | ACTCAGACAT ATAGCTGCTC CCTTGAGGAC CCCACGTGGA TGTCTCATGG ACACTTGAGC 60
TTATCAAGGG CTAAAGAGAT CTGGTCACCC CCAGCCAAAC CTGCCTACCC TGTAGCTCCT 120
CCATCTCTCC CTTCTAGTCC AGCAGGTCCC AAAGCCTGAA GTTGTCCTTG ACTTCTCTCT 180
AGCCTTCACG CTCACACGTC AGTTCCATCT GCCACATCAC CCAGAATCCG TCCGCATCTC 240
TCCACTTCTA CAACCTCCAC CATCGTGCAT GTCTGGACCA ATGAAGTCGC CTCCTGGCTC 300
TCCAGGAGTC CACCCTCACC TCCGCCACCA GAGGGCGCCT GTGAACACCT GCGTCGAGCA 360
TGCCCCTCCT CTGCTCAAAA CCCTCCAGGG CTCTCACCTT AATCCAAGCA AAGCCCAAGC 420
GTCTCCTTGC AGCCCACGAG GCCCTACGCG ATCTGCATTT GTTCTCCCTC TGTTCTGTTC 480
TGGCTCCCCA CACTCTCCCT GTTGCCCCCT GTGTTCCAGC CACACTGGCC TCCTTCGGGT 540
TTCTTGAACA GGCCAGTCAT GCTGCCACTC CAGGGCCTAC TCCCACCACC CTCAGTTTTC 600
TTTCTTTTTC TTTCTTTCTT TCTTTCTTTT TTTTTTTTTT TTGAGAAAGA GTTTTCTTCT 660
GTCGCCCAGG CTGGAGTGCA ATGGCGGGAT CTCGGCTCAC TGCAAGCTCC GCCTCCCGGG 720
TTCACGCCAT TCTCCTGCCT CAGCCTCCGG AGTAGCTGGG 760
|
